中、低预混胰岛素类似物对2型糖尿病患者血糖波动的影响-东南大学学报医学版

中、低预混胰岛素类似物对2型糖尿病患者血糖波动的影响

作者：李婷¹ 2 张颖³ 李凤飞³ 朱红红³ 周佩华³ 孙进³ 卢春峰³ 苏晓飞³ 马建华¹ 3

单位：1. 南京医科大学, 江苏南京 210029;
2. 南京卫生学校, 江苏联合职业技术学院南京卫生分院护理系, 江苏南京 210038;
3. 南京医科大学附属南京医院(南京市第一医院)内分泌科, 江苏南京 210012

关键词：精蛋白锌重组赖脯胰岛素混和注射液50R 门冬胰岛素30注射液血糖波动 2型糖尿病

分类号：R587.1

出版年·卷·期（页码）：2017·36·第三期（323-327）

摘要：

目的：比较精蛋白锌重组赖脯胰岛素混和注射液50R （优泌乐50）和门冬胰岛素30注射液（诺和锐30）对2型糖尿病（T2DM）患者血糖波动的影响。方法：入组T2DM患者持续皮下输注胰岛素强化，血糖达标2 d后行优泌乐50或诺和锐30每日3次治疗，血糖再次达标后进入4 d交叉研究，全程96 h动态血糖监测（CGM）覆盖。结果：优泌乐50和诺和锐30对患者24 h平均血糖、平均血糖波动幅度（MAGE）、高血糖（>10.0 mmol·L^-1）和低血糖（<3.9 mmol·L^-1）曲线下面积（AUC）等差异均无统计学意义；但相同剂量的优泌乐50较诺和锐30能更好地改善男性患者的MAGE[（4.52±2.50）vs（5.53±1.90） mmol·L^-1，P <0.05]；两组患者均无低血糖事件发生。结论：中、低预混胰岛素类似物对T2DM患者总人群血糖波动的影响相似，但中预混胰岛素能更好地控制男性T2DM患者血糖波动。

Objective:To compare the effect of mixed protamine zinc recombinant human insulin lispro injection 50R(Humalog Mix 50)with that of insulin aspart 30 injection(Novo Mix 30)on glycemic variations in patients with type 2 diabetes mellitus(T2DM). Methods:The recruited patients were treated with continuous subcutaneous insulin infusion for achieving euglycemic control.The patients were then treated with Humalog Mix 50 or Novo Mix 30 thrice-daily for another 2 days followed by 4-day cross-over treatment. Continuous glucose monitoring(CGM)was performed in all the subjects for at least 96 hours during the cross-over study period. The 24 hour mean glucose(24 hr MG), the mean amplitude of glycemic excursions(MAGE)and the incremental area under curve(AUC)of glucose concentrations above 10 mmol·L^-1 or less than 3.9 mmol·L^-1 were analyzed. Results:There were no significant differences in the 24 hr MG, the MAGE and the incremental AUC>10.0 mmol·L^-1 or <3.9 mmol·L^-1 between the groups. However, the MAGE was significantly improved in male patients with T2DM treated with Humalog Mix 50 compared with those treated with Novo Mix 30[(4.52±2.50)vs(5.53±1.90)mmol·L^-1,P<0.05]. Conclusion:T2DM patients treated with middle or low premixed insulin analogue have similar improvement of glycemic variations. Moreover, male patients treated with middle premixed insulin analogue get better improvement in glycemic variations compared with those treated with low premixed insulin analogue therapy.

参考文献：

[1] YANG W Y,LU J M,WENG J P,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
[2] MONNIER L,MAS E,GINET C,et al.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J].JAMA,2006,295(14):1681-1687.
[3] ZAFAR M I,AI X Q,SHAFQAT R A,et al.Effectiveness and safety of humalog Mix 50/50 versus humalog Mix 75/25 in Chinese patients with type 2 diabetes[J].Ther Clin Risk Manag,2015,11:27-32.
[4] GARBER A J,WAHLEN J,WAHL T,et al.Attainment of glycaemic goals in type 2 diabetes with once-,twice-,or thrice-daily dosing with biphasic insulin aspart 70/30(The 1-2-3 study)[J].Diabetes Obes Metab,2006,8(1):58-66.
[5] BU S,RUAN D J,YANG Z J,et al.Sex-specific prevalence of diabetes and cardiovascular risk factors in the middle-aged population of china:a subgroup analysis of the 2007-2008 China national diabetes and metabolic disorders study[J].PLoS One,2015,10(9):e0139039.
[6] 左鹏飞,马根山.糖尿病急性心肌梗死患者的临床特点及随访研究[J].东南大学学报:医学版,2014,33(2):182-186.
[7] 郭立新.中比例预混胰岛素类似物在胰岛素治疗中的地位[J].中国糖尿病杂志,2015,23(2):189-192.
[8] International Diabetes Federation Guideline Development Group.Guideline for management of post meal glucose in diabetes[J].Diabetes Res Clin Pract,2014,103:256-268.
[9] JIA W P,XIAO X H,JI Q H,et al.Comparison of thrice-daily premixed insulin(insulin lispro premix)with basal-bolus(insulin glargine once-daily plus thrice-daily prandial insulin lispro)therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin:an open-label,randomised,controlled trial[J].Lancet Diabetes Endocrinol,2015,3(4):254-262.
[10] WENG J P,LI Y B,XU W,et al.Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes:a multicentre randomised parallel-group trial[J].Lancet,2008,371(9626):1753-1760.
[11] REZNIK Y,COHEN O,ARONSON R,et al.Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes(OpT2mise):a randomised open-label controlled trial[J].Lancet,2014,384(9950):1265-1272.
[12] 郭晓珍,张晓兰,俞海燕.动态血糖监测对评估HbAlc<6.5%的2型糖尿病患者无症状低血糖事件的临床意义[J].现代医学,2011,39(4):406-408.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录